News
Search here results
search-total-matching124search-total-matching- Cancer in a time of COVID – keeping vital research and treatment on track | UCL Cancer Institute - UCL – University College London
- Genetic changes in tumours could help predict if patients will respond to immunotherapy | UCL Cancer Institute - UCL – University College London
- Nicholas McGranahan selected as EMBO Young Investigator 2020 | UCL Cancer Institute - UCL – University College London
- COVID-19: Fall in cancer treatment rose following ‘rapid’ NHS guidance | UCL Cancer Institute - UCL – University College London
- New immunotherapy shows promise against rare childhood cancer | UCL Cancer Institute - UCL – University College London
- Interview: Developing a new immunotherapy to gain control of cancer | UCL Cancer Institute - UCL – University College London
- Next-generation immunotherapy entering early phase clinical trials | UCL Cancer Institute - UCL – University College London
- Monitoring mitochondrial activitity to identify 'young' stem cells | UCL Cancer Institute - UCL – University College London
- Insight into immune cell activation could help identify Covid-19 patients most at risk of pneumonia | UCL Cancer Institute - UCL – University College London
- Scientists uncover order in cancer’s chromosomal chaos | UCL Cancer Institute - UCL – University College London
Please enable JavaScript to use this page or visit this page for a non javascript version.